Baxter International Inc (BAX)

79.70
-0.19(-0.24%)
After Hours
79.70
0.00(0.00%)
- Real-time Data
  • Volume:
    1,783,497
  • Bid/Ask:
    79.50/80.60
  • Day's Range:
    79.68 - 80.34

BAX Overview

Prev. Close
79.89
Day's Range
79.68-80.34
Revenue
12.2B
Open
80
52 wk Range
73.12-88.32
EPS
2.18
Volume
1,783,497
Market Cap
39.84B
Dividend (Yield)
1.12
(1.40%)
Average Volume (3m)
3,241,180
P/E Ratio
36.55
Beta
0.61
1-Year Change
-1.07%
Shares Outstanding
499,910,255
Next Earnings Date
Feb. 03, 2022
What is your sentiment on Baxter International Inc?
or
Market is currently closed. Voting is open during market hours.

Baxter International Inc News

Baxter International Inc Analysis

  • Stock Profile: Baxter International Inc.
    • ByTalkmarkets-

    Baxter International reported second-quarter sales increased a healthy 14% to $3.1 billion with net income increasing 22% to $301 million and EPS jumping 23% to $0.59.

  • Baxter’s $10.5 Bln Deal Is Preventative Medicine
    • ByTalkmarkets-

    In business as in medicine, preventing an ailment can be better than curing it. Baxter makes everything from dialysis machines to prefilled saline bags and expects sales to expand...

  • Podcast: Financial Market Preview - Monday 30-Aug
    • ByFactSet Research Systems Inc-

    US futures are indicating a slightly higher open as of 05:00 ET. Asian markets were largely positive on Monday. European markets are mixed in a relatively quiet session with UK...

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellBuy
Technical IndicatorsStrong SellStrong SellBuyStrong SellStrong Sell
SummaryStrong SellStrong SellNeutralStrong SellNeutral

Baxter International Inc Company Profile

Baxter International Inc Company Profile

Employees
50000

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.